| Reaction Details |
|---|
 | Report a problem with these data |
| Target | B2 bradykinin receptor |
|---|
| Ligand | BDBM50403721 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEBML_40107 |
|---|
| Ki | 11900±n/a nM |
|---|
| Citation |  Dziadulewicz, EK; Brown, MC; Dunstan, AR; Lee, W; Said, NB; Garratt, PJ The design of non-peptide human bradykinin B2 receptor antagonists employing the benzodiazepine peptidomimetic scaffold. Bioorg Med Chem Lett9:463-8 (1999) [PubMed] |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| B2 bradykinin receptor |
|---|
| Name: | B2 bradykinin receptor |
|---|
| Synonyms: | B2 BRADYKININ | B2 bradykinin receptor | B2R | BDKRB2 | BK-2 receptor | BKR2 | BKRB2_HUMAN | Bradykinin B2 receptor |
|---|
| Type: | Enzyme Catalytic Domain |
|---|
| Mol. Mass.: | 44467.17 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | B2 BRADYKININ BDKRB2 HUMAN::P30411 |
|---|
| Residue: | 391 |
|---|
| Sequence: | MFSPWKISMFLSVREDSVPTTASFSADMLNVTLQGPTLNGTFAQSKCPQVEWLGWLNTIQ
PPFLWVLFVLATLENIFVLSVFCLHKSSCTVAEIYLGNLAAADLILACGLPFWAITISNN
FDWLFGETLCRVVNAIISMNLYSSICFLMLVSIDRYLALVKTMSMGRMRGVRWAKLYSLV
IWGCTLLLSSPMLVFRTMKEYSDEGHNVTACVISYPSLIWEVFTNMLLNVVGFLLPLSVI
TFCTMQIMQVLRNNEMQKFKEIQTERRATVLVLVVLLLFIICWLPFQISTFLDTLHRLGI
LSSCQDERIIDVITQIASFMAYSNSCLNPLVYVIVGKRFRKKSWEVYQGVCQKGGCRSEP
IQMENSMGTLRTSISVERQIHKLQDWAGSRQ
|
|
|
|---|
| BDBM50403721 |
|---|
| n/a |
|---|
| Name | BDBM50403721 |
|---|
| Synonyms: | CHEMBL2111994 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C30H27N5O |
|---|
| Mol. Mass. | 473.5683 |
|---|
| SMILES | [#7]\[#6](-[#7])=[#7]/c1cccc(-[#6]-[#7]-2-c3ccccc3-[#6](=[#7]-[#6@H](-[#6]-c3ccccc3)-[#6]-2=O)-c2ccccc2)c1 |r,c:18| |
|---|
| Structure | 
|
|---|
Search and Browse
